Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Pharmacology & Therapeutics|April 20, 2020
An overview on anti-tubulin agents for the treatment of lymphoma patientsMarilia Barreca, Anastasios Stathis, Paola Barraja, et al.Current Medicinal Chemistry|August 19, 2007
DNA minor groove binders: an overview on molecular modeling and QSAR approachesAntonino Lauria, Alessandra Montalbano, Paola Barraja, et al.European Journal of Medicinal Chemistry|July 23, 2019
Targeting multiple myeloma with natural polyphenolsFanny Pojero, Paola Poma, Virginia Spanò, et al.Exploration of Targeted Anti-Tumor Therapy|January 19, 2023
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidencesMarilia Barreca, Noémie Lang, Chiara Tarantelli, et al.Drug Discovery Today|October 18, 2023
Advances in developing noncovalent small molecules targeting Keap1Marilia Barreca, Yuting Qin, Marie Elodie Hélène Cadot, et al.International Journal of Molecular Sciences|April 28, 2023
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein-Protein Interaction and Targeting by Triazole-Based Compounds through In Silico ApproachesRoberta Bivacqua, Isabella Romeo, Marilia Barreca, et al.Farmaco (Societa Chimica Italiana : 1989)|March 21, 2002
2-Diazoindoles: building blocks for the synthesis of antineoplastic agentsPaola Barraja, Patrizia Diana, Antonino Lauria, et al.Bioorganic & Medicinal Chemistry|May 18, 2010
Synthesis and antitumor activity of 2,5-bis(3'-indolyl)-furans and 3,5-bis(3'-indolyl)-isoxazoles, nortopsentin analoguesPatrizia Diana, Anna Carbone, Paola Barraja, et al.Bioorganic & Medicinal Chemistry Letters|October 4, 2007
3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor propertiesPatrizia Diana, Anna Carbone, Paola Barraja, et al.European Journal of Medicinal Chemistry|July 19, 2019
Furocoumarins as multi-target agents in the treatment of cystic fibrosisAnna Carbone, Alessandra Montalbano, Virginia Spanò, et al.Pageof 9